Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
The Journal of Emergency Medicine
|
January 1, 1986
The Wenckebach phenomenon
G J Fromell, J Root, R Barish
The American Journal of Cardiology
|
December 1, 2001
Prospective comparison of hemorrhagic complications after treatment with enoxaparin versus unfractionated heparin for unstable angina pectoris or non-ST-segment elevation acute myocardial infarction
S D Berkowitz, S Stinnett, M Cohen, et al.
Clinical Cardiology
|
September 1, 1994
Conversion from immediate-release to extended-release diltiazem in angina pectoris
P E Pool, U Thadani, A B Miller, et al.
The American Journal of Cardiology
|
July 15, 1994
Fluvastatin with and without niacin for hypercholesterolemia
T A Jacobson, M M Chin, G J Fromell, et al.
Journal of the American College of Cardiology
|
November 18, 2000
Low molecular weight heparin decreases rebound ischemia in unstable angina or non-Q-wave myocardial infarction: the Canadian ESSENCE ST segment monitoring substudy
S G Goodman, A Barr, A Sobtchouk, et al.
American Heart Journal
|
May 29, 2000
Predictors of recurrent ischemic events and death in unstable coronary artery disease after treatment with combination antithrombotic therapy
M Cohen, S S Stinnett, B D Weatherley, et al.
The New England Journal of Medicine
|
August 14, 1997
A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group
M Cohen, C Demers, E P Gurfinkel, et al.
The American Journal of Cardiology
|
September 16, 1998
Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary Events
M Cohen, C Demers, E P Gurfinkel, et al.
Journal of the American College of Cardiology
|
September 15, 2000
Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: one-year results of the ESSENCE Study. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q Wave Coronary Events
S G Goodman, M Cohen, F Bigonzi, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
The Journal of Emergency Medicine
|
January 1, 1986
The Wenckebach phenomenon
G J Fromell, J Root, R Barish
The American Journal of Cardiology
|
December 1, 2001
Prospective comparison of hemorrhagic complications after treatment with enoxaparin versus unfractionated heparin for unstable angina pectoris or non-ST-segment elevation acute myocardial infarction
S D Berkowitz, S Stinnett, M Cohen, et al.
Clinical Cardiology
|
September 1, 1994
Conversion from immediate-release to extended-release diltiazem in angina pectoris
P E Pool, U Thadani, A B Miller, et al.
The American Journal of Cardiology
|
July 15, 1994
Fluvastatin with and without niacin for hypercholesterolemia
T A Jacobson, M M Chin, G J Fromell, et al.
Journal of the American College of Cardiology
|
November 18, 2000
Low molecular weight heparin decreases rebound ischemia in unstable angina or non-Q-wave myocardial infarction: the Canadian ESSENCE ST segment monitoring substudy
S G Goodman, A Barr, A Sobtchouk, et al.
American Heart Journal
|
May 29, 2000
Predictors of recurrent ischemic events and death in unstable coronary artery disease after treatment with combination antithrombotic therapy
M Cohen, S S Stinnett, B D Weatherley, et al.
The New England Journal of Medicine
|
August 14, 1997
A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group
M Cohen, C Demers, E P Gurfinkel, et al.
The American Journal of Cardiology
|
September 16, 1998
Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary Events
M Cohen, C Demers, E P Gurfinkel, et al.
Journal of the American College of Cardiology
|
September 15, 2000
Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: one-year results of the ESSENCE Study. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q Wave Coronary Events
S G Goodman, M Cohen, F Bigonzi, et al.
Page
of 1